101 related articles for article (PubMed ID: 22698882)
1. Thrombotic complications associated with stem cell transplantation.
Nadir Y; Brenner B
Blood Rev; 2012 Sep; 26(5):183-7. PubMed ID: 22698882
[TBL] [Abstract][Full Text] [Related]
2. Hemorrhagic and thrombotic complications in bone marrow transplant recipients.
Nadir Y; Brenner B
Thromb Res; 2007; 120 Suppl 2():S92-8. PubMed ID: 18023720
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
Shimoni A; Yeshurun M; Hardan I; Avigdor A; Ben-Bassat I; Nagler A
Biol Blood Marrow Transplant; 2004 Jul; 10(7):484-93. PubMed ID: 15205669
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic complications after haematopoietic stem cell transplantation: early and late effects.
Tsakiris DA; Tichelli A
Best Pract Res Clin Haematol; 2009 Mar; 22(1):137-45. PubMed ID: 19285280
[TBL] [Abstract][Full Text] [Related]
5. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation.
Takatsuka H; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H
Clin Transplant; 2005 Jun; 19(3):418-22. PubMed ID: 15877808
[TBL] [Abstract][Full Text] [Related]
7. Nephrotic syndrome associated with thrombotic microangiopathy following allogeneic stem-cell transplantation for myelodysplastic syndrome.
Nakamura Y; Yujiri T; Ando T; Hisano S; Tanizawa Y
Br J Haematol; 2007 Mar; 136(6):857-9; author reply 859-60. PubMed ID: 17341274
[No Abstract] [Full Text] [Related]
8. Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.
Lesesve JF; Alla F; Dugué F; Salignac S; Clément L; Lecompte T; Bordigoni P
Int J Lab Hematol; 2011 Aug; 33(4):343-56. PubMed ID: 21284831
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathy following allogeneic bone marrow transplantation.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
Bone Marrow Transplant; 1999 Aug; 24(3):303-6. PubMed ID: 10455370
[TBL] [Abstract][Full Text] [Related]
10. Early complications following haematopoietic SCT in children.
Miano M; Faraci M; Dini G; Bordigoni P;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S39-42. PubMed ID: 18545243
[TBL] [Abstract][Full Text] [Related]
11. Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation.
Iguchi A; Kobayashi R; Kaneda M; Kobayashi K
Pediatr Blood Cancer; 2010 Mar; 54(3):437-43. PubMed ID: 19911420
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
Batts ED; Lazarus HM
Bone Marrow Transplant; 2007 Oct; 40(8):709-19. PubMed ID: 17603513
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
Iguchi A; Kobayashi R; Yoshida M; Kobayashi K; Matsuo K; Kitajima I; Maruyama I
Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
[TBL] [Abstract][Full Text] [Related]
14. Acute phase after haematopoietic stem cell transplantation: bleeding and thrombotic complications.
Graf L; Stern M
Hamostaseologie; 2012; 32(1):56-62. PubMed ID: 22008984
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation.
Belford A; Myles O; Magill A; Wang J; Myhand RC; Waselenko JK
Am J Hematol; 2004 Jun; 76(2):156-62. PubMed ID: 15164383
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
Ho V; Momtaz P; Didas C; Wadleigh M; Richardson P
Rev Clin Exp Hematol; 2004 Jun; 8(1):E3. PubMed ID: 16029969
[TBL] [Abstract][Full Text] [Related]
17. TIPS for veno-occlusive disease following stem cell transplantation.
Schoppmeyer K; Lange T; Wittekind C; Niederwieser D; Caca K
Z Gastroenterol; 2006 Jun; 44(6):483-6. PubMed ID: 16773513
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of soluble adhesion molecules in stem cell transplantation-related complications.
Matsuda Y; Hara J; Osugi Y; Tokimasa S; Fujisaki H; Takai K; Ohta H; Kawa-Ha K; Okada S
Bone Marrow Transplant; 2001 May; 27(9):977-82. PubMed ID: 11436109
[TBL] [Abstract][Full Text] [Related]
19. Animal models of thrombosis.
Bodary PF; Eitzman DT
Curr Opin Hematol; 2009 Sep; 16(5):342-6. PubMed ID: 19550319
[TBL] [Abstract][Full Text] [Related]
20. Using rheopheresis for stem cell transplantation-associated thrombotic microangiopathy (TA-TMA).
González-Vicent M; Herrero B; Guillén M; Sevilla J; Díaz MÁ
Transfus Apher Sci; 2013 Oct; 49(2):234-7. PubMed ID: 23768689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
